Evidence map›Paper›PMID 36135754›Full record

ArticleMarine drugs2022

Actinoflavosides B-D, Flavonoid Type Glycosides from Tidal Mudflat-Derived Actinomyces.

Hyeongju Jeong, Se Jin Jo, Munhyung Bae, Young Ran Kim, Kyuho Moon

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Cebulactam AMarine drugs · 2026
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hyeongju JeongResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju 61186, Korea.
Se Jin JoResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju 61186, Korea.
Munhyung BaeCollege of Pharmacy, Gachon University, Incheon 21936, Korea.
Young Ran KimResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju 61186, Korea.
Kyuho MoonResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju 61186, Korea.
Chonnam National University · KRGachon University · KR

Funding

Korea Basic Science Institute under the R&D program C230430National Research Foundation of Korea(NRF) grant 2021R1C1C100960912National Research Foundation of Korea(NRF) grant 2022R1A4A3022401
6 · The paper itself

Abstract

Three new secondary metabolites, actinoflavosides B-D (

Indexed as

ActinomycesGlycosidesAnimalsAnti-Bacterial AgentsFlavonoidsInterleukin-2MiceMolecular StructureAnti-Bacterial AgentsFlavonoidsGlycosidesInterleukin-2actinoflavosideantibacterialflavonoidimmune modulatorsecondary metabolitestructural determinationtidal mudflat

Identifiers

PMID36135754
PMCPMC9503743
OpenAlexW4294845531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.